| Name | NCT-502 |
|---|
| Description | NCT-502 is a human phosphoglycerate dehydrogenase (PHGDH) inhibitor, cytotoxic to PHGDH-dependent cancer cells, and reduces glucose-derived serine production, with an IC50 of 3.7 μM against PHGDH[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 3.7 μM (PHGDH)[1] |
| In Vitro | NCT-502 is cytotoxic to MDA-MB-468, with an EC50 of 15.2 µM[1]. |
| References |
| Molecular Formula | C18H20F3N5S |
|---|---|
| Molecular Weight | 395.45 |
| Storage condition | 2-8℃ |